Dr. Zhang awarded NIH 1U01 Research Project grant

Circular RNAs and their interactions with RNA-binding proteins to modulate AD-related neuropathology Dr. Xiaoling Zhang awarded NIH 1U01 Research Project grant New variants, especially in non-coding regions, are expected to be discovered through the ongoing Alzheimer’s Disease Sequencing Project (ADSP).  In 2020, NIA launched the ADSP Functional Genomics Initiative (RFA-AG-21-006) to strengthen the translational pathways […]

Dr. Sherva awarded NIH R01 Grant

Exploring mechanisms driving microbe-induced AD risk using next generations sequence data Dr. Richard Sherva awarded NIH R01 grant Multiple lines of evidence suggest microbial infections are risk factors for Alzheimer’s disease (AD). Amyloid-β (Aβ) peptides possess antimicrobial activity and may protect against human herpes viruses (HHV). Viral DNA is also detectable in Aβ plaques, and […]

Dr. Gyungah Jun Faculty Promotion

CONGRATULATIONS! Dr. Gyungah Jun, BUSM, Medicine/Biomedical Genetics, is a genetic epidemiologist who focuses on “big data” driven drug discovery for Alzheimer’s disease (AD). Dr. Jun has been involved in the large U.S. and international consortia to identify AD risk genes with or without stratification by APOE genotypes across multi-ethnic populations. This effort led to an […]

Dr. Zhang honored as a recipient of the 2021 Spivack Young Investigator Award

Dr. Xiaoling Zhang has been honored as the recipient of the 2021 Spivack Young Investigator Award as part of the Jack Spivack Excellence in Neuroscience Awards. These awards were established in 2013 to honor the work of outstanding BUSM faculty conducting research in Parkinson’s (PD), Alzheimer’s (AD), Chronic Traumatic Encephalopathy (CTE) and other neurological disorders. Dr. […]